Palo Alto Investors LP Relmada Therapeutics, Inc. Transaction History

Palo Alto Investors LP

  • $442 Million
  • Q2 2025

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Feb 14, 2025
SELL
$0.35 - $3.65 $83,038 - $865,977
-237,254 Reduced 32.39%
495,146 $257,000
Q2 2023

Aug 14, 2023
BUY
$2.22 - $3.54 $422,466 - $673,662
190,300 Added 35.1%
732,400 $1.8 Million
Q1 2023

May 15, 2023
BUY
$2.24 - $4.76 $1.21 Million - $2.58 Million
542,100 New
542,100 $1.23 Million

Others Institutions Holding RLMD

# of Institutions
55
Shares Held
5.43M
Call Options Held
0
Put Options Held
0
View Full List

About RELMADA THERAPEUTICS, INC.

RLMD Quotes by TradingView
  • Ticker RLMD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 28,608,500
  • Market Cap $16.9M
  • Description
  • Relmada Therapeutics, Inc., a clinical-stage biotechnology company, focuses on developing various products for the treatment of central nervous system (CNS) diseases and other disorders. Its lead product candidate is Esmethadone (d-methadone, dextromethadone, and REL-1017), a new chemical entity and N-methyl-D-aspartate receptor antagonist that ...
More about RLMD
Track This Portfolio

Track Palo Alto Investors LP Portfolio

Follow Palo Alto Investors LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Palo Alto Investors LP, based on Form 13F filings with the SEC.

News

Stay updated on Palo Alto Investors LP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email